Impact of stent strut design in metallic stents and biodegradable scaffolds
- PMID: 25449502
- DOI: 10.1016/j.ijcard.2014.09.143
Impact of stent strut design in metallic stents and biodegradable scaffolds
Abstract
Advances in the understanding of healing mechanisms after stent implantation have led to the recognition of stent strut thickness as an essential factor affecting re-endothelialization and overall long term vessel healing response after Percutaneous Coronary Interventions (PCI). Emergence of Drug-eluting stents (DESs) with anti-proliferative coating has contributed to reducing the incidence of restenosis and Target Lesion Revascularization (TVR), while progress and innovations in stent materials have in the meantime facilitated the design of newer platforms with more conformability and thinner struts, producing lesser injury and improving integration into the vessel wall. Recent advances in biodegradable metal and polymer materials now also allow for the design of fully biodegradable platforms, which are aimed at scaffolding the vessel only temporarily to prevent recoil and constrictive remodeling of the vessel during the initial period required, and are then progressively resorbed thereby avoiding the drawback of leaving an unnecessary implant permanently in the vessel. The aim of this article is to review recent evolution in stent material and stent strut design while understanding their impact on PCI outcomes. The article describes the different metallic alloys and biodegradable material properties and how these have impacted the evolution of stent strut thickness and ultimately outcomes in patients.
Keywords: Bioabsorbable scaffolds; DES; Neointimal coverage; PCI; Re-endothelialization; Strut thickness.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6. EuroIntervention. 2009. PMID: 22100674 Review.
-
Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.Circ Cardiovasc Interv. 2015 Jun;8(6):e002427. doi: 10.1161/CIRCINTERVENTIONS.115.002427. Circ Cardiovasc Interv. 2015. PMID: 26022535
-
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18. JACC Cardiovasc Interv. 2013. PMID: 24055443 Clinical Trial.
-
Coronary drug-eluting stents: from design optimization to newer strategies.J Biomed Mater Res A. 2014 May;102(5):1625-40. doi: 10.1002/jbm.a.34806. Epub 2013 Jul 1. J Biomed Mater Res A. 2014. PMID: 23703913 Review.
-
From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Expert Rev Med Devices. 2016;13(3):271-86. doi: 10.1586/17434440.2016.1143356. Epub 2016 Feb 12. Expert Rev Med Devices. 2016. PMID: 26782080 Review.
Cited by
-
Synchrotron microtomography reveals insights into the degradation kinetics of bio-degradable coronary magnesium scaffolds.Bioact Mater. 2023 Sep 23;32:1-11. doi: 10.1016/j.bioactmat.2023.09.008. eCollection 2024 Feb. Bioact Mater. 2023. PMID: 37771679 Free PMC article.
-
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326. EuroIntervention. 2023. PMID: 37334655 Free PMC article. Clinical Trial.
-
Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials.Open Heart. 2022 Oct;9(2):e002107. doi: 10.1136/openhrt-2022-002107. Open Heart. 2022. PMID: 36288820 Free PMC article.
-
Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics?Eur J Med Res. 2018 Jan 8;23(1):2. doi: 10.1186/s40001-017-0300-y. Eur J Med Res. 2018. PMID: 29310720 Free PMC article.
-
A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial.Cardiol Res. 2023 Aug;14(4):291-301. doi: 10.14740/cr1498. Epub 2023 Jul 12. Cardiol Res. 2023. PMID: 37559713 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous